The Mounjaro Jab on the NHS: Who Qualifies and What Comes Next

What does the NHS actually say about the Mounjaro jab right now?

NICE recommended tirzepatide for weight management in December 2024, published as technology appraisal TA1026. That recommendation matters enormously, but it did not open a door for everyone. NHS England decided to implement access in phases, partly because of the scale of potential demand and partly to build the clinical infrastructure needed to support patients properly.

The first cohort went live in June 2025. To qualify, you need a BMI of 40 or above and four or more of five specific conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. In June 2026, a second cohort opened for adults with a BMI between 35 and 39.9 who also have four or more of those same conditions. A third expansion (BMI 40 or above with three conditions) is planned for around March 2027.

For people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds, the BMI thresholds used throughout are 2.5 kg/m² lower, in line with UK guidance on ethnicity and cardiometabolic risk.

Every NHS patient must also take part in a wrap-around programme covering diet, activity and behavioural support. Meeting the numerical criteria does not guarantee access; referral pathways and waiting times vary by area. The NHS England guidance on weight management injections sets out the full requirements.

Can a GP prescribe the Mounjaro jab directly?

From 1 April 2026, GP practices can prescribe tirzepatide under the updated GP contract as part of the QOF framework for 2026/27. This was a significant development because it removed the requirement for a specialist referral for eligible patients in participating practices.

The catch (and it is a real one) is that participation is entirely optional. Some GP practices have enrolled; others have not, whether because of prescribing budget pressures, limited local support services, or simply the administrative weight of running a new pathway. So even if you meet the clinical criteria exactly, whether your own GP practice can offer this depends on where you live and which commissioning decisions your local integrated care board has made.

If you are unsure whether your practice is participating, asking the practice manager directly is the fastest route to an answer. It is also worth knowing that, regardless of which cohort eventually covers you, all NHS prescriptions come alongside the requirement for structured lifestyle support — the medicine is not prescribed in isolation. For a fuller picture of how the NHS Mounjaro pathway works in practice, including what that wrap-around care involves, that page covers it in detail.

What if you don't meet the NHS criteria, or simply can't wait?

This is the question most people are really asking. The NHS thresholds are deliberately strict, and the phased rollout means that millions of adults who could benefit clinically will not be eligible until later cohorts open, if at all. For someone with a BMI of 34 and one weight-related condition, the NHS route currently offers nothing.

Private prescription is the legal alternative. A GPhC-registered online pharmacy can prescribe Mounjaro following a clinical assessment, working to the licensed criteria in the medicine's Summary of Product Characteristics: adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition. The prescriber reviews your answers, medical history and any relevant records, and decides whether treatment is appropriate.

If you're wondering how the process of getting the Mounjaro jab through a private clinic or pharmacy actually works, the steps are more straightforward than many people expect. At nume, a GPhC-registered Independent Prescriber reads your consultation personally, the same day, on working days. There is no algorithm making the call. Once approved, treatment is dispatched the same day if ordered before 12pm and arrives with DPD the next working day, in plain unbranded packaging.

Cost is a reasonable concern. Private Mounjaro prices have risen since Eli Lilly adjusted UK list pricing in September 2025, and typical private prices now range roughly £149–£375 per month depending on dose and provider, as widely reported at the time. If you want to understand what those prices do and don't include across the market, the cost context page covers that honestly. The short version: the right question for a prescription medicine is not which listing is cheapest, but whether the supply chain, clinical oversight and aftercare are legitimate.

Is Mounjaro on the NHS the same medicine as what you'd get privately?

Yes. Whether prescribed via an NHS pathway or by a private prescriber, Mounjaro is tirzepatide manufactured by Eli Lilly, supplied through the licensed UK supply chain, and dispensed from a GPhC-registered pharmacy. The pen, the dose schedule, the Black Triangle monitoring status, the storage requirements, all identical. A prescription is a prescription.

The practical differences sit in the surrounding support: NHS prescribing comes with mandated wrap-around lifestyle services, whereas private clinics and pharmacies vary in the aftercare they provide. If you are considering whether Mounjaro jabs on the NHS are a realistic option for you right now, that page sets out the eligibility criteria and current access landscape clearly. At nume, 7-day aftercare is included as standard, and every repeat order is clinically reviewed before it is dispensed, there are no subscriptions and no auto-renewals.

One storage note that often surprises people: Mounjaro pens need to be kept refrigerated between 2°C and 8°C. Many people keep theirs in the fridge door, which works well as long as the temperature stays consistent. For the exact room-temperature window if you're travelling, always check the Patient Information Leaflet that comes with your pen rather than relying on general guidance, since that detail matters clinically. If you are spending time abroad and wondering whether you can fulfil your Mounjaro prescription outside the UK, that page covers the key considerations around international supply and what to plan for.

If you're ready to explore whether private treatment could be right for you, you can find out more about how to buy the Mounjaro jab through a registered UK pharmacy and start a free consultation with our prescribers. There's no obligation, no upfront cost, and your answers are read by a real clinician.